Mitsubishi UFJ Trust & Banking Corp Trims Position in Agilent Technologies, Inc. (NYSE:A)

Mitsubishi UFJ Trust & Banking Corp lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 9.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 210,020 shares of the medical research company’s stock after selling 21,802 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.07% of Agilent Technologies worth $23,484,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Norges Bank acquired a new position in shares of Agilent Technologies during the 4th quarter valued at about $393,291,000. Victory Capital Management Inc. boosted its position in shares of Agilent Technologies by 939.8% during the 3rd quarter. Victory Capital Management Inc. now owns 2,296,512 shares of the medical research company’s stock valued at $256,796,000 after acquiring an additional 2,075,649 shares during the last quarter. Morgan Stanley raised its holdings in Agilent Technologies by 79.4% in the 4th quarter. Morgan Stanley now owns 4,145,767 shares of the medical research company’s stock valued at $620,414,000 after buying an additional 1,835,413 shares during the period. Van ECK Associates Corp raised its holdings in Agilent Technologies by 120.8% in the 3rd quarter. Van ECK Associates Corp now owns 2,596,227 shares of the medical research company’s stock valued at $290,310,000 after buying an additional 1,420,430 shares during the period. Finally, Findlay Park Partners LLP purchased a new stake in Agilent Technologies in the 3rd quarter valued at about $107,097,000.

Insider Buying and Selling

In related news, VP Rodney Gonsalves sold 1,500 shares of Agilent Technologies stock in a transaction on Monday, December 18th. The stock was sold at an average price of $137.69, for a total transaction of $206,535.00. Following the completion of the sale, the vice president now directly owns 26,133 shares of the company’s stock, valued at $3,598,252.77. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, VP Rodney Gonsalves sold 1,500 shares of the business’s stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $137.69, for a total value of $206,535.00. Following the sale, the vice president now directly owns 26,133 shares in the company, valued at $3,598,252.77. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Philip Binns sold 2,880 shares of the company’s stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $139.78, for a total value of $402,566.40. Following the sale, the senior vice president now owns 12,824 shares in the company, valued at approximately $1,792,538.72. The disclosure for this sale can be found here. Insiders sold a total of 95,929 shares of company stock valued at $12,730,599 over the last three months.

Agilent Technologies Trading Down 0.5 %

Agilent Technologies stock opened at $133.34 on Monday. The business has a 50 day moving average price of $133.27 and a two-hundred day moving average price of $122.01. The company has a quick ratio of 1.97, a current ratio of 2.61 and a debt-to-equity ratio of 0.47. The stock has a market cap of $39.07 billion, a price-to-earnings ratio of 31.67, a price-to-earnings-growth ratio of 3.04 and a beta of 1.11. Agilent Technologies, Inc. has a 12 month low of $96.80 and a 12 month high of $155.75.

Agilent Technologies (NYSE:AGet Free Report) last issued its earnings results on Monday, November 20th. The medical research company reported $1.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.04. The business had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 28.24% and a net margin of 18.15%. Agilent Technologies’s quarterly revenue was down 8.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.53 EPS. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.48 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd were paid a $0.236 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.23. This represents a $0.94 annualized dividend and a dividend yield of 0.71%. The ex-dividend date was Friday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is 22.33%.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. UBS Group lowered shares of Agilent Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $163.00 to $125.00 in a report on Friday, November 17th. Robert W. Baird reduced their price objective on shares of Agilent Technologies from $140.00 to $130.00 and set an “outperform” rating on the stock in a report on Tuesday, November 21st. Bank of America lowered shares of Agilent Technologies from a “buy” rating to a “neutral” rating and boosted their price target for the stock from $130.00 to $133.00 in a research note on Tuesday, December 12th. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $160.00 to $145.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 22nd. Finally, JPMorgan Chase & Co. boosted their price target on shares of Agilent Technologies from $140.00 to $165.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 20th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $137.44.

Check Out Our Latest Analysis on Agilent Technologies

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Articles

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.